Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
J05AB18 Molnupiravir
D11943 Molnupiravir (JAN/USAN) <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
625 Antivirals
6250 Antivirals
D11943 Molnupiravir (JAN/USAN)
Drug groups [BR:br08330]
Antiviral
DG03174 Anti-SARS-CoV-2 agent
D11943 Molnupiravir
Drug classes [BR:br08332]
Antiviral
DG03174 Anti-SARS-CoV-2 agent
D11943 Molnupiravir
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
Other inhibitor
D11943 Molnupiravir (JAN/USAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11943
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D11943
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11943